{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:05:19Z","timestamp":1761962719041,"version":"3.38.0"},"reference-count":92,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T00:00:00Z","timestamp":1287619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Advances in Cardiovascular Disease"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:p> Atrial fibrillation is the most common sustained rhythm disturbance. Thromboembolic events related to atrial fibrillation result in significant morbidity, mortality and increases in the cost of healthcare. Anticoagulants are pivotal agents for the prevention and treatment of thromboembolic disorders. The latest American College of Cardiology\/American Heart Association guidelines recommend antithrombotic therapy to prevent thromboembolism for all patients with atrial fibrillation, except those with lone atrial fibrillation or contraindications. Vitamin K antagonists were first synthesized in 1948 and for the past six decades they have been the only agents used for long-term oral anticoagulant therapy. Although these drugs are effective, they have numerous limitations, which have led to the development of newer anticoagulant therapies. The emerging oral anticoagulant agents are target selective. They have predictable pharmacokinetic and pharmacodynamic parameters and do not require routine monitoring. They are not associated with significant food and drug interactions, and can be administered in simple fixed daily or twice daily doses. This article reviews the current literature on various targets for anticoagulant therapy and newer oral anticoagulants for atrial fibrillation. <\/jats:p>","DOI":"10.1177\/1753944710386844","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T03:44:54Z","timestamp":1287719094000},"page":"395-407","source":"Crossref","is-referenced-by-count":5,"title":["Recent advances in oral anticoagulation for atrial fibrillation"],"prefix":"10.1177","volume":"4","author":[{"given":"Mukesh","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Cardiology, Mount Sinai Hospital, 1500 California Avenue, Chicago, IL 60608, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasikanth","family":"Adigopula","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mount Sinai Hospital, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawan","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mount Sinai Hospital, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kranti","family":"Kiran","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mount Sinai Hospital, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Khosla","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mount Sinai Hospital, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2010,10,21]]},"reference":[{"key":"atypb1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.177031","volume":"114","author":"ACC\/AHA\/ESC","year":"2006","journal-title":"Circulation"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02436.x"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V106.11.278.278"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.6.690"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.204S"},{"key":"atypb6","first-page":"295","volume":"34","author":"Antithrombotic Therapy in Atrial Fibrillation Study Group","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"atypb7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","volume":"154","author":"Atrial Fibrillation Investigators","year":"1994","journal-title":"Arch Intern Med"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2006.1.450"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00813-9"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.1.41"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1517\/13543780802528625"},{"volume-title":"A multi-center, placebo-controlled evaluation of the safety and efficacy of three weeks extended VTE prophylaxis with daily oral doses of TTP889 after one week of standard prophylactic treatment following hip fracture surgery (FIXIT)","author":"ClinicalTrials.gov: NCT00119457.","key":"atypb12"},{"volume-title":"A phase 3, active (warfarin) controlled, randomized, double-blind, parallel arm study to evaluate efficacy and safety of apixaban in preventing stroke and systemic embolism in subjects with nonvalvular atrial fibrillation (ARISTOTLE)","author":"ClinicalTrials.gov: NCT00412984.","key":"atypb13"},{"volume-title":"Direct factor Xa inhibitor YM150 for prevention of stroke in subjects with non-valvular atrial fibrillation: A double blind, parallel, dose-finding study in comparison with open label warfarin","author":"ClinicalTrials.gov: NCT00448214.","key":"atypb14"},{"volume-title":"Evaluation of the efficacy and safety of rivaroxaban (BAY59-7939) for the prevention of stroke and non-central nervous system systemic embolism in subjects with nonvalvular atrial fibrillation","author":"ClinicalTrials.gov: NCT00494871.","key":"atypb15"},{"volume-title":"Apixaban versus acetylsalicylic acid (ASA) to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment: A randomized double blind trial (AVERROES)","author":"ClinicalTrials.gov: NCT00496769.","key":"atypb16"},{"volume-title":"Randomized dabigatran etexilate dose finding study in patients with acute coronary syndromes post index event with additional risk factors for cardiovascular complications also receiving aspirin and clopidogrel: Multi-centre, prospective, placebo controlled, cohort dose escalation study (RE-DEEM)","author":"ClinicalTrials.gov: NCT00621855.","key":"atypb17"},{"volume-title":"A phase 3, randomized, double-blind, double-dummy, parallel group, multi-center, Multi-national study for evaluation of efficacy and safety of DU-176b versus warfarin in subjects with atrial fibrillation: Effective anticoagulation with factor Xa next generation in atrial fibrillation (ENGAGE-AF TIMI-48)","author":"ClinicalTrials.gov: NCT00781391.","key":"atypb18"},{"volume-title":"RELY-ABLE long term multi-center extension of dabigatran treatment in patients with atrial fibrillation who completed the RE-LY trial and a cluster randomised trial to assess the effect of a knowledge translation intervention on patient outcomes","author":"ClinicalTrials.gov: NCT00808067.","key":"atypb19"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90585-W"},{"key":"atypb22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"Connolly, S.","year":"2006","journal-title":"Lancet"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92358-Z"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.2165\/0003088-200948010-00001"},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02644.x"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14841-6"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211123272002"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.06.034"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1177\/1753944709346517"},{"key":"atypb30","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(87)90174-7","volume":"1","author":"Flegel, K.M.","year":"1987","journal-title":"Lancet"},{"key":"atypb31","first-page":"1852","volume":"104","author":"Fukuda, T.","year":"2004","journal-title":"American Society of Hematology annual meeting. Blood"},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V104.11.1851.1851"},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0906886"},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.02.065"},{"key":"atypb35","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.18.2370"},{"key":"atypb36","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.108.162677"},{"key":"atypb37","first-page":"3825","volume":"112","author":"Gruber, A.","year":"2008","journal-title":"American Society of Hematology annual meeting"},{"key":"atypb38","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb07410.x"},{"key":"atypb39","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.14.1513"},{"key":"atypb40","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"atypb41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7215.958"},{"key":"atypb42","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.8S"},{"key":"atypb43","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.64S"},{"key":"atypb44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)09233-2"},{"key":"atypb45","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V108.11.911.911"},{"key":"atypb46","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80348-9"},{"key":"atypb47","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0043-5"},{"key":"atypb48","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006286904"},{"key":"atypb49","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006296058"},{"key":"atypb50","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)99165-9"},{"key":"atypb51","doi-asserted-by":"publisher","DOI":"10.1161\/hc2601.091386"},{"key":"atypb52","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.23.3028"},{"key":"atypb53","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V112.11.983.983"},{"key":"atypb54","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","volume":"370","author":"Mant, J.","year":"2007","journal-title":"Lancet"},{"key":"atypb55","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-12-200312160-00012"},{"key":"atypb56","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.595140"},{"key":"atypb57","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.28.5.1015"},{"key":"atypb58","doi-asserted-by":"publisher","DOI":"10.5414\/CPP45335"},{"key":"atypb59","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.1.432"},{"key":"atypb60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2007.12.005"},{"key":"atypb61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14841-6"},{"key":"atypb62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.05.084"},{"key":"atypb63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01166.x"},{"key":"atypb64","first-page":"482","volume":"323","author":"Petersen, P.","year":"1990","journal-title":"N Engl J Med"},{"key":"atypb65","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91200-2"},{"key":"atypb66","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1021\/jm070245n","volume":"50","author":"Pinto, D.J.","year":"2007","journal-title":"J Med Chem"},{"key":"atypb67","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615593"},{"key":"atypb68","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.7.2455"},{"key":"atypb69","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.10.1913"},{"key":"atypb70","first-page":"340","volume":"159","author":"Rocket AF","journal-title":"Am Heart J"},{"key":"atypb71","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V106.11.1886.1886"},{"key":"atypb72","doi-asserted-by":"publisher","DOI":"10.1126\/science.2374926"},{"key":"atypb73","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe038152"},{"key":"atypb74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.12.5518"},{"key":"atypb75","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.148304"},{"key":"atypb76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.5.2149"},{"key":"atypb77","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.567297"},{"key":"atypb78","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","volume":"84","author":"Stroke Prevention in Atrial Fibrillation Study Group","year":"1991","journal-title":"Circulation"},{"key":"atypb79","first-page":"687","volume":"343","author":"Stroke Prevention in Atrial Fibrillation II Study Group","year":"1994","journal-title":"Lancet"},{"key":"atypb80","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011293232201"},{"key":"atypb81","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544120-00003"},{"key":"atypb82","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.19.2441"},{"key":"atypb83","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/eurheartj\/26.suppl_1.403","volume":"26","author":"Wallentin, L.","year":"2005","journal-title":"Eur Heart J"},{"key":"atypb84","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.95S"},{"key":"atypb85","doi-asserted-by":"publisher","DOI":"10.1161\/hc0802.104331"},{"key":"atypb86","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V112.11.33.33"},{"key":"atypb87","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(02)00093-2"},{"key":"atypb88","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370090041008"},{"key":"atypb89","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.8.983"},{"key":"atypb90","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.10.973"},{"key":"atypb91","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"Writing ACTIVE Group","year":"2006","journal-title":"Lancet"},{"key":"atypb92","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-04-0312"}],"container-title":["Therapeutic Advances in Cardiovascular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753944710386844","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753944710386844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T20:33:11Z","timestamp":1740774791000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1753944710386844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,21]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1177\/1753944710386844"],"URL":"https:\/\/doi.org\/10.1177\/1753944710386844","relation":{},"ISSN":["1753-9447","1753-9455"],"issn-type":[{"type":"print","value":"1753-9447"},{"type":"electronic","value":"1753-9455"}],"subject":[],"published":{"date-parts":[[2010,10,21]]}}}